United States · Health Care · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Quoin Pharmaceuticals, Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -141.59% | -304.02% | 148.89% | 59.71% | 37.36% | 27.38% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -87.56% | -85.64% | -95.2% | -94.94% | -94.86% | -95.58% |
| Total Assets | $20,390,569.00 | $16,572,473.00 | $16,572,473.00 | $16,572,473.00 | $16,572,473.00 | $16,572,473.00 |
| Sector average | $3,280,499,225.95 | $3,298,345,309.75 | $3,676,894,011.56 | |||
| Net Income | -$15,804,655.00 | -$15,827,673.02 | -$15,777,142.72 | -$15,733,953.84 | -$15,721,354.75 | -$15,840,485.72 |
| $4,262,561,283.40 |
| $4,994,412,918.01 |
| $5,761,557,240.51 |